Prognostic value of echocardiographically assessed right ventricular dysfunction in patients with pulmonary embolism

Wolde, M. Ten; Söhne, Maaike; Quak, Elske; Macgillavry, M. R.; Büller, HR

doi:10.1016/j.accreview.2004.10.031

Cited by 37 publications

(53 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Several previous studies have suggested that pulmonary arterial embolic burden assessed by CT as well as by RV/LV ratio is also a predictor for APTE patients (9)(10)(11)(12)(13)(14)(15)(16)(17)(18)(19)(20). On the other hand, Ghaye et al (19) suggested that RV/LV diameter ratio and azygos vein diameter were significant predictors, and that pulmonary arterial embolic burden was not.…”

Section: Discussionmentioning

confidence: 98%

“…According to the past literatures (14)(15)(16)(17)(18)(19)(20), the scans were evaluated by measuring the minor axes of the right and left ventricles of the heart in the transverse plane at their widest points between the inner surface of the free wall and the surface of the interventricular septum. These maximum dimensions may be found at different levels.…”

Section: Contrast-enhanced Ctmentioning

confidence: 99%

“…Currently, multidetector-row CT (MDCT) pulmonary angiography can be used to identify clots within distal pulmonary arteries (PAs) with high sensitivity and specificity, and can indicate alternative diagnoses and underlying lung diseases. In addition, some investigators have used several parameters to evaluate the accuracy of CT scoring systems for PA clot assessment as well as right ventricular (RV) failure assessment (9)(10)(11)(12)(13)(14)(15)(16)(17)(18)(19)(20). MDCT has therefore become the first imaging examination for suspected acute PTE (APTE) patients (9)(10)(11)(12)(13)(14)(15)(16)(17)(18)(19)(20).…”

mentioning

confidence: 99%

“…In addition, some investigators have used several parameters to evaluate the accuracy of CT scoring systems for PA clot assessment as well as right ventricular (RV) failure assessment (9)(10)(11)(12)(13)(14)(15)(16)(17)(18)(19)(20). MDCT has therefore become the first imaging examination for suspected acute PTE (APTE) patients (9)(10)(11)(12)(13)(14)(15)(16)(17)(18)(19)(20). In addition, the ratio between the diameter of the RV and of the left ventricle (LV), the RV/LV ratio, and embolic burden have been associated with patient outcome (11,(16)(17)(18)(19)(20).…”

mentioning

confidence: 99%

“…MDCT has therefore become the first imaging examination for suspected acute PTE (APTE) patients (9)(10)(11)(12)(13)(14)(15)(16)(17)(18)(19)(20). In addition, the ratio between the diameter of the RV and of the left ventricle (LV), the RV/LV ratio, and embolic burden have been associated with patient outcome (11,(16)(17)(18)(19)(20).…”

mentioning

confidence: 99%

See 4 more Smart Citations

Dynamic MR perfusion imaging: Capability for quantitative assessment of disease extent and prediction of outcome for patients with acute pulmonary thromboembolism

Ohno

Koyama

Matsumoto

et al. 2010

Magnetic Resonance Imaging

View full text Add to dashboard Cite

Purpose: To compare directly the capabilities of multidetector-row computed tomography (MDCT) and MRI for disease severity assessment and outcome prediction for acute pulmonary thromboembolism (APTE) patients. Materials and Methods:Fifty consecutive APTE patients underwent MDCT, MR angiography, dynamic perfusion MRI, treatment and follow-up examination. Pulmonary blood flow (PBF), pulmonary blood volume, and mean transit time maps were generated from perfusion MRI, and all segmental parameters were determined by using region of interest measurements. Receiver operator curve analyses were used to determine the most accurate parameter for diagnosis of the APTE segment. Then, APTE index from perfusion MRI (PE perfusion MRI index), right ventricle/left ventricle (RV/LV) diameter ratio and APTE indexes from embolic burdens observed on MDCT (PE CT index) and MR angiography (PE MRA index) were calculated. Finally, ability to differentiate mortality (n ¼ 8) from survival (n ¼ 42) groups and to predict patient outcome were statistically assessed.Results: PBF was a significantly more accurate parameter than others (P < 0.05). When feasible threshold value was applied, specificity and accuracy of RV/LV diameter ratio and PE Perfusion MRI index were significantly higher than those of PE CT and PE MRA indexes (P < 0.05). Logistic regression analysis demonstrated that each index was a significant predictor (P < 0.05).Conclusion: Dynamic perfusion MRI can be effective for disease extent assessment and outcome prediction for APTE patients.

show abstract

Section: Discussionmentioning

confidence: 98%

Section: Contrast-enhanced Ctmentioning

confidence: 99%

mentioning

confidence: 99%

mentioning

confidence: 99%

mentioning

confidence: 99%

See 3 more Smart Citations

Dynamic MR perfusion imaging: Capability for quantitative assessment of disease extent and prediction of outcome for patients with acute pulmonary thromboembolism

Ohno

Koyama

Matsumoto

et al. 2010

Magnetic Resonance Imaging

View full text Add to dashboard Cite

show abstract

Prognostic Role of Echocardiography Among Patients With Acute Pulmonary Embolism and a Systolic Arterial Pressure of 90 mm Hg or Higher

Kucher¹,

Rossi²,

Rosa³

et al. 2005

Arch Intern Med

378

228

View full text Add to dashboard Cite

show abstract

Contrast‐enhanced multidetector‐row computed tomography vs. Time‐resolved magnetic resonance angiography vs. contrast‐enhanced perfusion MRI: Assessment of treatment response by patients with inoperable chronic thromboembolic pulmonary hypertension

Ohno

Koyama

Yoshikawa

et al. 2012

Magnetic Resonance Imaging

View full text Add to dashboard Cite

Purpose: To compare therapeutic effect assessment capability of multidetector-row computed tomography (MDCT), magnetic resonance angiography (MRA), and dynamic perfusion MRI for chronic thromboembolic pulmonary hypertension (CTEPH) patients.Materials and Methods: Twenty-four consecutive CTEPH patients treated with conventional therapy underwent pre-and posttherapeutic MDCT, MRA, dynamic perfusion MRI, 6-minute walk distance (6-MWD), cardiac ultrasound (US), and right heart catheterization. According to therapeutic results, all patients were divided into response (n ¼ 13) and nonresponse (n ¼ 11) groups. CTEPH indexes for MDCT (CTEPH CT ) and MRA (CTEPH MRA ) were calculated on the basis of embolic burden. Pulmonary perfusion parameter maps were generated from all perfusion MR data, followed by determination of improvements in mean perfusion parameter at regions of interest (ROIs) for each patient. Receiver operating characteristic (ROC)-based positive tests were performed to determine the feasible threshold values for distinguishing two groups. Finally, diagnostic capabilities were compared by means of McNemar's test.Results: When feasible threshold values adapted, specificity (90.9 h10/11i%, P < 0.05) and accuracy (95.8 h23/ 24i%, P < 0.05) for improvement in pulmonary blood flow were significantly higher than those for CTEPH CTA (specificity: 36.4 h4/11i%, accuracy: 70.8 h17/24i%). Conclusion:Dynamic perfusion MRI has better capability for assessment of therapeutic effect on CTEPH patients than does MDCT.

show abstract

Prognostic value of echocardiographically assessed right ventricular dysfunction in patients with pulmonary embolism

Cited by 37 publications

References 0 publications

Dynamic MR perfusion imaging: Capability for quantitative assessment of disease extent and prediction of outcome for patients with acute pulmonary thromboembolism

Dynamic MR perfusion imaging: Capability for quantitative assessment of disease extent and prediction of outcome for patients with acute pulmonary thromboembolism

Prognostic Role of Echocardiography Among Patients With Acute Pulmonary Embolism and a Systolic Arterial Pressure of 90 mm Hg or Higher

Contrast‐enhanced multidetector‐row computed tomography vs. Time‐resolved magnetic resonance angiography vs. contrast‐enhanced perfusion MRI: Assessment of treatment response by patients with inoperable chronic thromboembolic pulmonary hypertension

Contact Info

Product

Resources

About